NOUREX
LIVE

Serial Number

97794497

Owner

ELANCO US INC.

Attorney

Aaron Sternhagen

Filing Date

Feb 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOUREX Trademark

Serial Number: 97794497

NOUREX is a trademark filed by ELANCO US INC. on February 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ELANCO US INC. (478 trademarks)

GREENFIELD, IN 46140

Entity Type: 03

Trademark Details

Filing Date

February 14, 2023

Registration Date

Not Registered

Published for Opposition

January 23, 2024

Goods & Services

Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 15, 2025 EX4G
SOU EXTENSION 4 FILED
Dec 15, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 29, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 29, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 29, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 5, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 12, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 12, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2023 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2023 CNSL
ASSIGNED TO EXAMINER
Sep 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2023 NWOS
NEW APPLICATION ENTERED
Feb 17, 2023 NWAP